Background Image
Table of Contents Table of Contents
Previous Page  56 / 56
Information
Show Menu
Previous Page 56 / 56
Page Background

Dyna Indapamide SR.

Each sustained release tablet contains 1,5 mg indapamide. Reg. No.: RSA S3 42/7.1/0790. NAM NS2 12/7.1/0138. For full prescribing information, refer to the package insert approved by the

Medicines Control Council, 25 November 2011.

1)

Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drug Safety 2001;24(15):1155-1165. 2) Department of Health website.

http://www.health.gov.za

– Accessed 28/04/2015.

DINC110/05/2015.

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Tel

021 707 7000

Fax

021 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

SUSTAINED

RELEASE

METABOLICALLY

NEUTRAL

1

Printed by Tandym Printers